Potassium Chloride for Oral Solution
NDC 10135-820, Potassium Chloride for Oral Solution, solution, from Marlex Pharmaceuticals Inc.
- Product NDC
- 10135-820
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals Inc
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212183
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CHLORIDE3 g/4.75g
Pharmacologic classes
Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-820-08 | 10135082008 | 3 g in 1 BOTTLE (10135-820-08) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3e78028d-21a0-ba0f-e063-6294a90aac49
Use it
Look up 10135-820 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-820 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-820. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.